» Authors » Cosmas Rinaldi A Lesmana

Cosmas Rinaldi A Lesmana

Explore the profile of Cosmas Rinaldi A Lesmana including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 1220
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nababan S, Aprilicia G, Akbar P, Kalista K, Jasirwan C, Kurniawan J, et al.
Acta Med Indones . 2024 Oct; 56(3):276-281. PMID: 39463109
Background: Spleen stiffness measurement (SSM) is a recently developed non-invasive method for predicting clinically significant portal hypertension and esophageal varices in compensated advanced liver disease or cirrhosis. This study aims...
2.
Gani R, Teressa M, Budiman R, Kalista K, Lesmana C
HPB (Oxford) . 2024 Jul; 26(10):1216-1228. PMID: 39060212
Introduction: Although studies have indicated comparable outcomes between RFA and surgical resection in early HCC, there is still unclear evidence of benefit in larger tumor sizes. This study aimed to...
3.
Sulaiman A, Hasan I, Lesmana C, Kurniawan J, Jasirwan C, Nababan S, et al.
Acta Med Indones . 2023 Jan; 54(4):567-573. PMID: 36624717
Background: Liver fibrosis is an essential factor in the management of Hepatitis C virus infection. Its assessment is crucial in decision-making regarding the therapeutic decisions, and the patients' follow up....
4.
Sulaiman A, Gani R, Hasan I, Lesmana C, Kurniawan J, Jasirwan C, et al.
J Gastrointest Cancer . 2021 Aug; 53(3):632-640. PMID: 34379264
Background: Radiofrequency ablation (RFA) is one of the curative modality therapies commonly used for the early stage of HCC management. Although numerous studies have reported the outcome of RFA around...
5.
Lesmana C, Paramitha M, Gani R
Can J Gastroenterol Hepatol . 2021 Jul; 2021:9948979. PMID: 34258255
Chronic liver disease (CLD) is still a major problem, where the disease progression will lead to liver cirrhosis (LC) or hepatocellular carcinoma (HCC). Portal hypertension (PH) management and loco-regional therapy...
6.
Verma N, Dhiman R, Singh V, Duseja A, Taneja S, Choudhury A, et al.
Hepatol Int . 2021 Jun; 15(3):753-765. PMID: 34173167
Background: Multiple predictive models of mortality exist for acute-on-chronic liver failure (ACLF) patients that often create confusion during decision-making. We studied the natural history and evaluated the performance of prognostic...
7.
Lesmana C, Pakasi L, Sudoyo A, Krisnuhoni E, Lesmana L
Can J Gastroenterol Hepatol . 2020 Dec; 2020:6676294. PMID: 33376713
Aim: Nonalcoholic fatty liver disease (NAFLD) has been known as a risk for the presence of colon polyp and CRC development. This study was aimed to find out the clinical...
8.
Koh C, Lakhtakia S, Kida M, Lesmana C, Ang T, Vu C, et al.
Endoscopy . 2020 Jul; 53(6):595-602. PMID: 32650341
Background: Although endoscopic ultrasound (EUS) features and criteria have been described in chronic pancreatitis, challenges remain with interoperator variability and ease of adoption. The aim of this study was to...
9.
Fang C, An J, Bruno A, Cai X, Fan J, Fujimoto J, et al.
Hepatol Int . 2020 Jul; 14(4):437-453. PMID: 32638296
Three-dimensional (3D) visualization involves feature extraction and 3D reconstruction of CT images using a computer processing technology. It is a tool for displaying, describing, and interpreting 3D anatomy and morphological...
10.
Lesmana C, Kalista K, Sandra S, Hasan I, Sulaiman A, Kurniawan J, et al.
JGH Open . 2020 Jun; 4(3):511-518. PMID: 32514463
Introduction: Gastric varices (GVs) occur in 10-30% of liver cirrhotic patients, with a mortality rate of up to 45%. Rupture of isolated GVs (IGVs) is less prevalent but often results...